Today: 21 May 2026
CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus
15 January 2026
2 mins read

CrowdStrike (CRWD) stock rises after judge tosses outage lawsuit, Seraphic deal in focus

NEW YORK, Jan 15, 2026, 12:50 EST — Regular session

  • CrowdStrike shares rose about 1% after a judge dismissed a shareholder fraud lawsuit tied to the 2024 outage.
  • Investors are also weighing CrowdStrike’s push into browser and identity security through fresh dealmaking.
  • Next up: closing timelines, any litigation spillover, and the next earnings update.

CrowdStrike Holdings Inc (CRWD.O) shares rose on Thursday after a U.S. judge dismissed a shareholder fraud lawsuit tied to the company’s July 2024 software outage. The stock was up 1.2% at $466.07 in midday trading, after closing at $460.70 in the prior session.

The ruling trims a legal overhang that has sat on the stock since the outage, when investors were already jittery about software quality controls at one of the market’s highest-profile cybersecurity vendors. It also lands in the middle of a broader debate about whether security budgets are shifting toward platform “bundles” or staying fragmented.

Deal talk has kept the ticker busy, too. CrowdStrike has agreed to buy browser runtime security firm Seraphic Security, and last week announced a $740 million deal for identity security startup SGNL as it tries to extend protection beyond laptops and servers and into logins and browser sessions — where a lot of work now happens.

In the lawsuit, U.S. District Judge Robert Pitman in Austin, Texas, said shareholders failed to plausibly allege that CrowdStrike and senior executives made materially false statements or acted with an intent to defraud. A spokesman for New York State Comptroller Thomas DiNapoli said the decision was “under review,” while CrowdStrike chief legal officer Cathleen Anderson said the company appreciated the court’s decision to dismiss the case. Reuters

CrowdStrike’s pitch on the Seraphic deal is simple: security teams can’t see enough inside the browser session, even though that’s where employees click links, log into apps and move data. CEO George Kurtz said the aim is to “turn any browser into a secure enterprise browser,” without forcing users to switch tools or change how they work. Built In Austin

Browser runtime security is meant to sit inside the session and catch threats such as phishing and “zero-day” exploits — attacks that hit before a vendor has issued a fix. SecurityWeek cited competitors in the enterprise browser security space including Menlo Security and LayerX, a reminder that CrowdStrike is pushing into a segment that already has specialists. SecurityWeek

Cybersecurity stocks were mixed on the day. Palo Alto Networks edged up, Zscaler and Fortinet were slightly higher, while SentinelOne slipped; identity-focused names Okta and CyberArk were little changed.

But the easy read — “lawsuit gone, stock up” — has limits. CrowdStrike still has to show that its acquisition push doesn’t dilute execution, and that customers keep expanding on the platform even as boards ask harder questions about outages, vendor concentration and contract terms.

Wall Street’s next hard checkpoint is earnings. Zacks expects CrowdStrike’s next results on March 3, and traders will be listening for any update on deal-closing timelines and how the company frames demand after a noisy stretch of legal and product headlines.

Stock Market Today

  • Teradyne, Kulicke and Soffa, Impinj, Microchip, IPG Photonics Stocks Slide on U.S.-China Semiconductor Summit Outcome
    May 21, 2026, 2:58 AM EDT. Shares of Teradyne, Kulicke and Soffa, Impinj, Microchip Technology, and IPG Photonics dropped sharply following the U.S.-China summit, which ended without key breakthroughs on semiconductor exports. Expectations for U.S. approval of Nvidia's H200 chip shipments to China were unmet, disappointing investors. U.S. Trade Representative Jamieson Greer indicated semiconductors were not a negotiation focus, dampening near-term optimism. Despite the sell-off, IPG Photonics' stock, known for volatility, remains down significantly from its 52-week high but has gained 34.3% year-to-date. Market reactions highlight cautious sentiment amid geopolitical tensions, with analysts skeptical about swift comprehensive deals due to national security concerns.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn
Previous Story

Opendoor Technologies stock slips today as mortgage applications surge and Treasuries stay stubborn

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead
Next Story

Philip Morris stock edges up after PMI flags $20B+ U.S. investment push, FDA ZYN review ahead

Go toTop